Silylation of bicyclic oxazine Nꢀoxides
Russ.Chem.Bull., Int.Ed., Vol. 55, No. 11, November, 2006 2069
For the mixture of the isomers Eꢀ23 and Zꢀ23, found (%):
C, 69.11; H, 7.48; N, 5.62; C15H19NO3; calculated (%): C, 68.94;
H, 7.33; N, 5.36.
4.4 Hz, J = 11.5 Hz); 2.00—2.25, 1.64—1.80 (both m, 2 H each,
CH2); 1.41—1.56 (m, 1 H, CH2); 1.16—1.40 (m, 3 H, CH2);
0.96—1.14 (m, 2 H, CH2). 13C NMR, δ: 155.1, 139.3, 128.9,
128.1, 127.5, 99.2, 80.1, 54.3, 45.6, 40.2, 32.4, 32.3, 27.8,
26.4, 25.5.
Methyl 7ꢀ(E )ꢀ9ꢀhydroxyiminoꢀ8ꢀphenylnonꢀ7ꢀenoate (Eꢀ24),
Rf 0.26 (AcOEt—hexane, 1 : 3). 1H NMR, δ: 8.40 (br.s, 1 H,
OH); 7.81 (s, 1 H, HC=N); 7.25—7.38 (m, 3 H, Ph); 7.10—7.18
Study of cationic intermediates in the silylation of sixꢀmemꢀ
bered cyclic nitronates (general procedure). A solution of a
nitronate (0.05 mmol) and 2,6ꢀdiꢀtertꢀbutylꢀ4ꢀmethylpyridine
(10 mg, 0.05 mmol) in CD2Cl2 (0.5 mL) was prepared in an
NMR tube filled with argon and closed with a septum. The tube
was cooled to 200 K and a silyl triflate (0.075 mmol; TMSOTf
for 29 and TBDMSOTf for 31) was added with a microsyringe.
The tube was rapidly shaken several times for homogenization
and placed in the cooled (210 K) probe of an NMR spectroꢀ
meter. The spectra of the starting nitronates and the sample with
silyl triflate are given below. The cationic intermediate derived
from compound 17a was assigned cyclic structure 29 since its
characteristic parameters in the NMR spectra were similar to
the corresponding parameters of cations obtained in the silylation
of sixꢀmembered cyclic nitronates.15 The cationic intermediate
derived from compound 30 was assigned acyclic structure 31
according to its spectrum. The characteristic signal in the
29Si NMR spectrum is typical of silyl nitronates.
Nitronate 17a. 1H NMR (CD2Cl2, –63 °C), δ: 7.25—7.40
(m, 3 H, Ph); 7.20 (d, 2 H, oꢀPh, J = 7.3 Hz); 6.21 (d, 1 H,
H(3), J = 2.5 Hz); 3.44 (dd, 1 H, H(4), J = 10.6 Hz, J = 2.3 Hz);
3.35 (s, 3 H, OMe); 2.14 (br.t, 1 H, H(4a), J ≈ 9.0 Hz); 1.92,
1.70 (both m, 1 H each, C(10)H2); 1.10—1.66 (m, 10 H,
C(5)H2—C(9)H2). 13C NMR (CD2Cl2, –63 °C), δ: 138.6
(s, Phipso); 128.6, 128.4, 127.3 (CH, Ph); 115.1 (C(3)); 108.9
(C(10a)); 49.2 (OMe); 44.2 (C(4)); 36.8 (C(4a)); 25.5 (2 C);
24.0, 23.8, 22.0, 21.0 (C(5)—C(10)).
Intermediate 29. 1H NMR (CD2Cl2, –63 °C), δ: 8.13 (d,
1 H, H(3), J = 2.3 Hz); 7.36—7.50 (m, 3 H, Ph); 7.20 (d, 2 H,
oꢀPh, J = 7.8 Hz); 3.97 (dd, 1 H, H(4), J = 11.5 Hz, J = 2.3 Hz);
3.47 (s, 3 H, OMe); 2.44 (br.t, 1 H, H(4a), J ≈ 9.0 Hz); 2.09,
2.30 (both m, 1 H each, C(10)H2); 1.84, 0.98—1.76 (2 m, 1 H
and 9 H, C(5)H2—C(9)H2); 0.45 (s, 9 H, SiMe3). 13C NMR
(CD2Cl2, –63 °C), δ: 143.2 (C(3)), 132.8 (s, Phipso); 129.6,
129.0 (CH, Ph); 122.0 (C(10a)); 119.5 (q, CF3); 51.8 (OMe);
45.0 (C(4)); 36.3 (C(4a)); 26.0, 24.4, 23.3, 22.7, 21.0, 20.4 (s,
CH2); 1.4 (Si(CH3)3). 29Si NMR (CD2Cl2, –63 °C), δ: 49.7.
Nitronate 30. 1H NMR (CD2Cl2, –63 °C), δ: 7.10—7.40
(m, 5 H, Ph); 3.80 (br.t, 4 H, C(11)H, C(12)H); 3.50 (d, 1 H,
H(4), J = 10.6 Hz); 3.40 (br.q, 4 H, C(9)H, C(10)H); 2.65—3.00
(3 m, 3 H, C(5)H, C(8)H, C(8a)H); 1.70 (s, 3 H, C(3)Me); 1.50
(m, 6 H, C(6)H2, C(7)H2), C(5)H, C(8)H). 13C NMR (CD2Cl2,
–63 °C), δ: 140.9 (s, Phipso); 128—130 (CH, Ph); 122.4 (C(3));
100.1 (C(8a)); 67.9 (C(11), C(12)); 46.9 (C(4)); 44.7, 44.0
(C(9), C(10)); 39.8 (C(4a)); 25.3, 23.2, 22.2, 18.0 (4 CH2);
22.0 (C(13)).
Intermediate 31. 1H NMR (CD2Cl2, –63 °C), δ: 7.47 (d,
2 H, oꢀPh, J = 7.3 Hz); 7.42 (t, 2 H, mꢀPh, J = 7.2 Hz); 7.36 (t,
1 H, pꢀPh, J = 7.1 Hz); 4.63 (d, 1 H, H(4), J = 11.7 Hz); 4.43
(ddd, 1 H, H(9), J = 13.4 Hz, J = 7.8 Hz, J = 3.2 Hz); 4.28 (m,
1 H, H(9) or H(10)); 4.21 (m, 1 H, H(9) or H(10)); 4.13 (br.d,
1 H, H(9) or H(10), J = 13.3 Hz); 4.22 (m, 1 H, H(4a)); 4.05,
3.92 (both m, 4 H, H(11), H(12)); 3.28 (td, 1 H, H(8), J =
12.5 Hz, J = 5.5 Hz); 3.20 (br.d, 1 H, H(8), J = 14.4 Hz); 2.28
(m, 1 H, H(7)); 1.96 (br.d, 1 H, H(5), J = 14.8 Hz); 1.90 (s, 3 H,
C(3)Me); 1.85 (m, 2 H, H(5), H(7)); 1.65, 1.48 (both m, 2 H,
3
(m, 2 H, Ph); 5.95 (t, 1 H, HC=C, J = 7.7 Hz); 3.66 (s, 3 H,
OMe); 2.22 (t, 2 H, CH2CO2, J = 7.3 Hz); 2.06 (q, 2 H,
CH2C=C, J = 7.3 Hz); 1.66 (tt, 2 H, CH2, J = 7.5 Hz); 1.51 (tt,
2 H, CH2, J = 7.1 Hz); 1.41 (tt, 2 H, CH2, J = 6.7 Hz).
13C NMR, δ: 174.0, 148.3, 140.1, 136.7, 135.6, 129.2, 128.6,
128.1, 51.5, 33.9, 29.2, 28.8, 28.6, 24.8.
Methyl 7ꢀ(Z )ꢀ9ꢀhydroxyiminoꢀ8ꢀphenylnonꢀ7ꢀenoate (Zꢀ24),
Rf 0.26 (AcOEt—hexane, 1 : 3). 1H NMR, δ: 8.28 (br.s, 1 H,
OH); 8.26 (s, 1 H, HC=N); 7.27—7.32 (m, 5 H, Ph); 5.92 (t,
1 H, HC=C, 3J = 7.7 Hz); 3.67 (s, 3 H, OMe); 2.34 (q, 2 H,
CH2C=C, J = 7.4 Hz); 2.32 (t, 2 H, CH2CO2, 3J = 7.3 Hz); 1.66
(tt, 2 H, CH2, J = 7.5 Hz); 1.51 (tt, 2 H, CH2, J = 7.1 Hz); 1.41
(tt, 2 H, CH2, J = 6.7 Hz). 13C NMR, δ: 174.0, 148.3,
139.5, 139.0, 134.5, 128.5, 128.0, 127.4, 51.5, 34.0, 29.1, 28.7,
28.0, 24.7.
For the mixture of Eꢀ24 and Zꢀ24, found (%): C, 69.99;
H, 7.53; N, 5.41; C16H21NO3; calculated (%): C, 69.79;
H, 7.69; N, 5.09.
erythroꢀ[1ꢀ(2ꢀMethoxycyclohexꢀ2ꢀenyl)ꢀ2ꢀnitroethyl]benꢀ
zene (25a), Rf 0.55 (AcOEt—hexane, 1 : 1). Found (%): C, 69.20;
H, 7.25; N, 5.19. C15H19NO3. Calculated (%): C, 68.94; H,
7.33; N, 5.36. 1H NMR, δ: 7.21—7.36 (m, 5 H, Ph); 4.83—4.90
(m, 1 H, CH=COCH3); 4.67—4.77 (m, 2 H, CH2NO2); 3.75
(dt, 1 H, CHPh, J = 6.0 Hz, J = 9.6 Hz); 3.52 (s, 3 H, OCH3);
2.42—2.50 (m, 1 H, CHCHPh); 2.04—2.15 (m, 2 H, CH2);
1.37—1.72 (m, 4 H, CH2). 13C NMR, δ: 155.2, 139.3, 128.7,
128.1, 127.9, 96.1, 80.0, 53.5, 47.2, 40.6, 25.6, 23.5, 18.3.
threoꢀ[1ꢀ(2ꢀMethoxycyclohexꢀ2ꢀenyl)ꢀ2ꢀnitroethyl]benzene
1
(25b), Rf 0.55 (AcOEt—hexane, 1 : 1). H NMR, δ: 7.10—7.40
(m, 5 H, Ph); 4.95 (dd, 1 H, CHNO2, J = 13.0 Hz, J = 10.7 Hz);
4.77 (t, 1 H, CH=COCH3, J = 3.0 Hz); 4.66 (dd, 1 H, CHNO2,
J = 13.4 Hz, J = 4.7 Hz); 4.00 (dt, 1 H, CHPh, J = 10.9 Hz, J =
3.8 Hz); 3.54 (s, 3 H, OCH3); 2.66 (m, 1 H, CHCHPh); 1.97
(m, 1 H, CH2); 1.86 (m, 1 H, CH2); 1.55—1.64 (m, 1 H, CH2);
1.25—1.40 (m, 3 H, CH2). 13C NMR, δ: 154.3, 138.3, 128.5,
128.2, 127.2, 97.4, 77.7, 53.9, 46.0, 41.8, 26.7, 23.6, 21.5.
For the mixture of 25a and 25b, found (%): C, 68.63; H, 7.00;
N, 5.55; C15H19NO3; calculated (%): C, 68.94; H, 7.33; N, 5.36.
Eꢀ1ꢀMethoxyꢀ7ꢀ(2ꢀnitroꢀ1ꢀphenylethyl)cycloheptene (26a),
Rf 0.51 (AcOEt—hexane, 1 : 3), m.p. 111—112 °C. Found (%):
C, 69.52; H, 7.54; N, 4.88. C16H21NO3. Calculated (%):
C, 69.79; H, 7.69; N, 5.09. 1H NMR, δ: 7.21—7.38 (m, 5 H,
Ph); 4.83—4.93 (m, 1 H, CH=COCH3); 4.57—4.66 (m, 2 H,
CH2NO2); 3.86—4.00 (m, 1 H, CHPh); 3.47 (s, 3 H, OCH3);
2.53—2.64 (m, 1 H, CHCHPh); 2.08—2.36 (m, 2 H, CH2);
1.24—1.83 (m, 6 H, CH2). 13C NMR, δ: 160.4, 138.8, 128.9,
127.9, 127.6, 98.7, 81.0, 54.2, 47.3, 44.2, 28.1, 27.2, 25.8, 24.3.
Eꢀ1ꢀMethoxyꢀ8ꢀ(2ꢀnitroꢀ1ꢀphenylethyl)cyclooctene (27a),
Rf 0.57 (AcOEt—hexane, 1 : 3), m.p. 58ꢀ59 °C. Found (%):
C, 70.29; H, 8.24; N, 4.56. C17H23NO3. Calculated (%):
C, 70.56; H, 8.01; N, 4.84. 1H NMR, δ: 7.18—7.38 (m, 5 H,
Ph); 4.80 (t, 1 H, CH=COCH3, J = 8.2 Hz); 4.64 (dd, 1 H,
CHNO2, J = 12.3 Hz, J = 4.5 Hz); 4.53 (dd, 1 H, CHNO2, J =
12.3 Hz, J = 10.5 Hz); 3.72 (dt, 1 H, CHPh, J = 4.5 Hz, J =
10.6 Hz); 3.54 (s, 3 H, OCH3); 3.01 (dt, 1 H, CHCHPh, J =